… Covidien (formerly United States Surgical, a division of Tyco Healthcare Group, L. P.) is conducting a FSCA of all production lots for the Duet TRS™ Universal Straight and Articulating Single Use Loading Units (SULU) with respect to the use … Continue reading →
Categories: Ideas For Surgery News |
Tags: Accelerate Globalization , Accelerated investments , Access to capital , acquisition of technologies , acromis implementation and development , address patients’ need , address the high risk , adoption of austerity measures , advantageous position , adverse impact on technology , age-related disease , angel investors , around the globe , Asia , Attain the desired level of proficiency , availability of capital to fund future innovation , between adjacent vertebrae , biggest long-term opportunity , biomedical cluster , biomedical company CEOs , Biomedical industry , biotechnology , Candidates in queue , CE Mark trial , CEO , choosing the right delivery method , clinical value , Collaborative partnership , commercialize medtech , Compete on price , Competitive landscape , considered as a first line therapy , corporate partnerships as a source of financing , Corporate venture funding , cost-effective solutions , Coverage and reimbursement issues , dealing with high risk complications , declining procedure volume , Deliver value , delivering better economic value , Demonstrate the economic value , Develop specific plans to accelerate global growth , devices approved for procedures , Devices priced at hefty premium , diagnostics or medical equipment , Disease foundations , Disruptive business model , Diverse funding sources , DUET4535 Duet TRS™ 45 3.5MM STRAIGHT SULU , DUET4535A Duet TRS™ 45 3.5MM ARTICULATING SULU , DUET4548 Duet TRS™ 45 4.8MM STRAIGHT SULU , DUET4548A Duet TRS™ 45 4.8MM ARTICULATING SULU , DUET6035 Duet TRS™ 60 3.5MM STRAIGHT SULU. DUET6035A Duet TRS™ 60 3.5MM ARTICULATING SULU , DUET6048 Duet TRS™ 60 4.8MM STRAIGHT SULU. DUET6048A Duet TRS™ 60 4.8MM ARTICULATING SULU , Economic potential , engaging primarily with the physician , Enrollment in pilot study , Europe , European Market , Evaluated the merits of products , Evolving Market , Expanding insights into markets , FDA regulatory approval process , first mover advantage , First-in-man , focus on emerging markets , Germany , global growth goals , global leadership position , Global Markets , government grants , Growth opportunity , implants capable of being inserted trans-laterally , Implementation , Improve Execution , Improving ability to attract investment and grow , increased pressure in utilization , infringed patents , Infringement Verdict , innovation and state-of-the-art medical technology , innovative technologies , Investment of corporate funds into external endeavors , Japan , Japanese market , key opinion leader KOL , Leading biomedical region , less invasive treatment , licensing agreements , Look for other solutions , Maintain high standards of safety and effectiveness , Major emerging markets , Medical devices , Medtronic , meet the urgent need of patients , Meeting the needs , multinational , nascent technologies , necessity of the procedures to be performed in specialized centers , Next-generation , Non-governmental organizations NGO , noninvasive , nullify a patent , NuVasive , Optimize Innovation , OUS market , Outside The USA (OUS) , overt risk , partnerships , pharmaceuticals , physicians’ learning curve , pivotal trial , plate and screw system , prevailing economic uncertainty , principle investigator , Prioritize investment , products in clinical development , progressive , proper selection of patients , Provider and payer levels , providing expertise. early clinical evidence , Raising money for a startup , recent launches , Recreate the ecosystem , Regulatory approval process in the world , Regulatory framework based on consistency , reimbursement pressure , restructuring initiatives , scheduled for completion , serial entrepreneur , slower growth of US markets , solutions that deliver better economic value , spinal fusion surgery , stabilize vertebrae in the cervical spine , Stakeholders , Standard of care , state-of-the-art procedure , sustainable growth , targeting a limited launch , tax incentives for innovation , Team work , threats to the biomedical industry’s growth , tissue retractor , Training of the physicians and staff , Uncertain regulatory environment , Under development , unfavorable reimbursement decision from the CMS , Unsuitable for open surgery , Venture Capital , Widespread rollout , Working collaboratively |
Permalink
